- October 10, 2011
  

Medical Software Availability for Tablet Devices Increases As They Become More Popular

- September 28, 2011
  

STOPping-Ventricular Tachycardia with Stereotaxis Ablation: Interview with Electrophysiologist Dr. Zyad Younan

- September 16, 2011
  

Performing heart surgery with the click of a mouse

- August 31, 2011
  

Stereotaxis' STOP-VT Prospective Multicenter Study Results Featured at Europe's Largest Medical Meeting, European Society of Cardiology

- March 3, 2011
  

Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook

- December 20, 2010
  

Stereotaxis Completes $40 Million Credit Facility

- November 30, 2010
  

Stereotaxis to Present at the Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference

- November 11, 2010
  

Stereotaxis Announces Pricing of $14.6 Million Common Stock Offering

- November 10, 2010
  

Stereotaxis Announces Public Offering of Common Stock

- November 10, 2010
  

Stereotaxis Receives Commitment to Increase and Extend Credit Facility

- November 1, 2010
  

Stereotaxis Reports Third Quarter Financial Results

- October 25, 2010
  

Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call

- September 8, 2010
  

Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients